Towards the integration, annotation and association of historical microarray experiments with RNA-seq

BMC Bioinformatics

Volumn 14, Issue SUPPL.14, 2013, Pages

  Chavan, Shweta S ^a   Bauer, Michael A ^a   Peterson, Erich A ^a   Heuck, Christoph J ^a   Johann Jr, Donald J ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL MANAGEMENT; CLUSTER ASSIGNMENT; MICROARRAY EXPERIMENTS; MODEL-VIEW-CONTROLLER; MOLECULAR UNDERSTANDING; NEXT-GENERATION SEQUENCING; TRANSCRIPTOME ANALYSIS; TRANSCRIPTOME RECONSTRUCTION;

BIOINFORMATICS; GENES; PROBES; RNA; TOOLS;

MICROARRAYS;

RNA; TRANSCRIPTOME;

ALGORITHM; CELL LINE; CHEMISTRY; COMPUTER PROGRAM; GENE EXPRESSION PROFILING; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; MOLECULAR GENETICS; PROCEDURES; SEQUENCE ANALYSIS; ARTICLE; METHODOLOGY;

ALGORITHMS; CELL LINE; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MOLECULAR SEQUENCE ANNOTATION; RNA; SEQUENCE ANALYSIS, RNA; SOFTWARE DESIGN; TRANSCRIPTOME;

EID: 84885200298     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-14-S14-S4     Document Type: Article

References (36)

1. Boguski MS, Arnaout R, Hill C. Customized care 2020: how medical sequencing and network biology will enable personalized medicine. F1000 Biol Rep 2009, 1:73. 2948270, 20948615.
2. Johann DJ, Blonder J. Biomarker discovery: tissues versus fluids versus both. Expert Rev Mol Diagn 2007, 7(5):473-475. 10.1586/14737159.7.5.473, 17892354.
3. Johann DJ, Wei BR, Prieto DA, Chan KC, Ye X, Valera VA, Simpson RM, Rudnick PA, Xiao Z, Issaq HJ, et al. Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma. Anal Chem 2010, 82(5):1584-1588. 10.1021/ac902204k, 3251958, 20121140.
4. Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med 2004, 351(18):1860-1873. 10.1056/NEJMra041875, 15509819.
5. Rajkumar SV. Treatment of multiple myeloma. Nat Rev Clin Oncol 2011, 8(8):479-491. 10.1038/nrclinonc.2011.63, 3773461, 21522124.
6. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300. 10.3322/caac.20073, 20610543.
7. Rajkumar SV, Gahrton G, Bergsagel PL. Approach to the treatment of multiple myeloma: a clash of philosophies. Blood 2011, 118(12):3205-3211. 10.1182/blood-2011-06-297853, 3179390, 21791430.
8. Barlogie B, Jagannath S, Desikan KR, Mattox S, Vesole D, Siegel D, Tricot G, Munshi N, Fassas A, Singhal S, et al. Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood 1999, 93(1):55-65.
9. Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, et al. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 2005, 352(24):2487-2498. 10.1056/NEJMoa043445, 15958804.
10. Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, et al. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 1999, 341(21):1565-1571. 10.1056/NEJM199911183412102, 10564685.
11. Shaughnessy JD, Zhan F, Burington BE, Huang Y, Colla S, Hanamura I, Stewart JP, Kordsmeier B, Randolph C, Williams DR, et al. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood 2007, 109(6):2276-2284. 10.1182/blood-2006-07-038430, 17105813.
12. Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S, Epstein J, Yaccoby S, Sawyer J, Burington B, et al. The molecular classification of multiple myeloma. Blood 2006, 108(6):2020-2028. 10.1182/blood-2005-11-013458, 1895543, 16728703.
13. Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 2003, 349(26):2483-2494. 10.1056/NEJMoa030847, 14695408.
14. Yaccoby S, Ling W, Zhan F, Walker R, Barlogie B, Shaughnessy JD. Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo. Blood 2007, 109(5):2106-2111. 10.1182/blood-2006-09-047712, 1801040, 17068150.
15. NCCN Clinical Practice Guidelines in Oncology, Breast Cancer, Version 2.2013., http://www.nccn.org
16. Nagaraj G, Ma CX. Adjuvant chemotherapy decisions in clinical practice for early-stage node-negative, estrogen receptor-positive, HER2-negative breast cancer: challenges and considerations. J Natl Compr Canc Netw 2013, 11(3):246-250. quiz 251.
17. Ross JS. Multigene predictors in early-stage breast cancer: moving in or moving out?. Expert Rev Mol Diagn 2008, 8(2):129-135. 10.1586/14737159.8.2.129, 18366299.
18. Kaklamani V. A genetic signature can predict prognosis and response to therapy in breast cancer: Oncotype DX. Expert Rev Mol Diagn 2006, 6(6):803-809. 10.1586/14737159.6.6.803, 17140367.
19. McDermott U, Downing JR, Stratton MR. Genomics and the continuum of cancer care. N Engl J Med 2011, 364(4):340-350. 10.1056/NEJMra0907178, 21268726.
20. Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006, 24(23):3726-3734. 10.1200/JCO.2005.04.7985, 16720680.
21. Sparano JA, Paik S. Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol 2008, 26(5):721-728. 10.1200/JCO.2007.15.1068, 18258979.
22. Cardoso F, Van't Veer L, Rutgers E, Loi S, Mook S, Piccart-Gebhart MJ. Clinical application of the 70-gene profile: the MINDACT trial. J Clin Oncol 2008, 26(5):729-735. 10.1200/JCO.2007.14.3222, 18258980.
23. Mook S, Van't Veer LJ, Rutgers EJ, Piccart-Gebhart MJ, Cardoso F. Individualization of therapy using Mammaprint: from development to the MINDACT Trial. Cancer Genomics Proteomics 2007, 4(3):147-155.
24. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009, 10(1):57-63. 10.1038/nrg2484, 2949280, 19015660.
25. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008, 5(7):621-628. 10.1038/nmeth.1226, 18516045.
26. Oshlack A, Robinson MD, Young MD. From RNA-seq reads to differential expression results. Genome Biol 2010, 11(12):220. 10.1186/gb-2010-11-12-220, 3046478, 21176179.
27. Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 2010, 11(10):685-696. 10.1038/nrg2841, 20847746.
28. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010, 28(5):511-515. 10.1038/nbt.1621, 3146043, 20436464.
29. Li W, Feng J, Jiang T. IsoLasso: a LASSO regression approach to RNA-Seq based transcriptome assembly. J Comput Biol 2011, 18(11):1693-1707. 10.1089/cmb.2011.0171, 3216102, 21951053.
30. Mangul S, Caciula A, Seesi SA, Brinza D, Banday AR, Kanadia R. An integer programming approach to novel transcript reconstruction from paired-end RNA-Seq reads. Proceedings of the ACM Conference on Bioinformatics, Computational Biology and Biomedicine. 2012, 369-376. Orlando, Florida: ACM.
31. Nicolae M, Mangul S, Zelikovsky A. Estimation of alternative splicing isoform frequencies from RNA-Seq data. Algorithms Mol Biol 2011, 6(1):9. 10.1186/1748-7188-6-9, 3107792, 21504602.
32. Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 2011, 12:323. 10.1186/1471-2105-12-323, 3163565, 21816040.
33. Shaughnessy JD, Qu P, Usmani S, Heuck CJ, Zhang Q, Zhou Y, Tian E, Hanamura I, van Rhee F, Anaissie E, et al. Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3. Blood 2011, 118(13):3512-3524. 10.1182/blood-2010-12-328252, 3186329, 21628408.
34. Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y. RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res 2008, 18(9):1509-1517. 10.1101/gr.079558.108, 2527709, 18550803.
35. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. Integrative genomics viewer. Nat Biotechnol 2011, 29(1):24-26. 10.1038/nbt.1754, 3346182, 21221095.
36. Frischmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 1999, 8(10):1893-1900. 10.1093/hmg/8.10.1893, 10469842.